Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Curr Opin Immunol. 2010 Feb 9;22(2):245–250. doi: 10.1016/j.coi.2010.01.011

Figure 2.

Figure 2

Embryonal stem cell antigens as targets of cancer immunity. Genes restricted to ES cells and cancer, but not expressed by normal adult stem cells or their differentiated progeny (shaded area) may be potential targets for cancer vaccines. Some of these genes can regulate stemness in both cancer and ES cells, and are the most attractive targets.